This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Jms Co., Ltd.. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Innovations by Kasumi Ogata in Hematopoietic Stem Cell Research
Introduction
Kasumi Ogata is an accomplished inventor based in Hiroshima, Japan. She has made significant contributions to the field of hematopoietic stem cell research. Her innovative work focuses on methods for controlling the proliferation and differentiation of cord blood-derived hematopoietic stem cells.
Latest Patents
Kasumi Ogata holds a patent titled "Method for controlling proliferation of cord blood hematopoietic stem cells and use thereof." This invention provides a method for regulating the proliferation and differentiation of cord blood-derived hematopoietic stem cells with excellent safety. The method involves culturing the stem cells in a medium containing a sonicated liquid component of cord blood. The presence of this component can inhibit the proliferation and differentiation of the stem cells. Conversely, using a non-sonicated liquid component can accelerate their proliferation. This innovative approach allows for the desired regulation of stem cell behavior using serum derived from cord blood.
Career Highlights
Kasumi Ogata is associated with Jms Co., Ltd., where she continues her research and development in the field of stem cell technology. Her work has the potential to impact medical treatments and therapies significantly.
Collaborations
Kasumi collaborates with Satoshi Hirai, who is also involved in research related to hematopoietic stem cells. Their partnership enhances the scope and depth of their innovative projects.
Conclusion
Kasumi Ogata's contributions to hematopoietic stem cell research exemplify the importance of innovation in medical science. Her patented methods offer promising avenues for future therapies and advancements in regenerative medicine.